Technology Solutions

Survey: Industry using medical imaging metrics to meet study milestones

Monday, November 21, 2011 09:09 AM

Boston-based Perceptive Informatics, an eClinical solutions provider and a subsidiary of CRO Parexel International, found in a global survey that over half (54%) of respondents review medical imaging-related study metrics on a regular basis. Of those respondents, 81% use medical imaging metrics as actionable data to inform progress toward the achievement of study milestones. Key performance indicators used by the respondents include the status of site qualification for imaging-based clinical trials, as well as progress of medical image submissions, query responses and radiology reviews.

More... »

Genexion selects goBalto's Tracker platform

Thursday, November 17, 2011 02:59 PM

SanFrancisco-based goBalto has entered a strategic partnership with Genexion, a CRO that has selected Tracker, goBalto's web-based clinical trials platform, for its clinical research study start-up and monitoring.

More... »

EP Clinical Trials links EudraCT and ClinicalTrials.gov

Tuesday, November 15, 2011 04:04 PM

London-based EvaluatePharma, a source for life science sector analysis, has launched its new clinical trial intelligence service, EP Clinical Trials. By linking EudraCT and ClinicalTrials.gov records, the new service delivers a unique synthesis of clinical trials information.

More... »

SVTC Technologies partners with SUSS MicroTec

Tuesday, November 15, 2011 01:18 PM

SVTC Technologies, a partner for accelerating nanotechnology development and commercialization, is partnering with SUSS MicroTec, an equipment supplier for MEMS and advanced 3D IC integration. This collaboration is targeted at supporting wafer-level processing for MEMS and 3D IC integration with focus on the newest bonding applications needed for next-generation electronics. The partnership with SUSS MicroTec continues an ongoing SVTC strategy to provide an ecosystem of partners all geared towards providing comprehensive value-added solutions to customers.

More... »

Clinilabs selects NewCardio's QTinnoŽ solution for phase I trial

Thursday, November 10, 2011 08:12 AM

NewCardio, a cardiovascular diagnostic solutions developer, has reported that its strategic partner, Clinilabs, will utilize QTinnoŽ, NewCardio's automated cardiac safety solution, to conduct a phase I trial of an investigational new drug under development for a central nervous system (CNS) indication.

More... »

Cedars-Sinai Medical Center selects Voalté's iPhone platform

Tuesday, November 8, 2011 03:25 PM

More... »

CoreRx launches FLEXITAB

Monday, November 7, 2011 12:27 PM

CoreRx has further enhanced its offering by adding the Bosch Manesty FLEXITAB, a fully automated, single station tablet press with a multi-layer tablet function, giving it the unique capacity to produce multi-layer (up to three-layer) tablets using a minimal amount of material. Its variable punch displacement and dwell time can be set to simulate compression on any rotary press using compression forces up to100kN.

More... »

Alnylamm, GSK collaborate in vaccine production

Thursday, November 3, 2011 01:13 PM

Alnylam Pharmaceuticals has formed a collaboration with GlaxoSmithKline focused on Alnylam's VaxiRNATM technology for certain GSK vaccine products, including influenza. VaxiRNA is a new RNAi technology for the enhanced production of viruses used in the manufacture of vaccine products. GSK is the first company to form a collaboration accessing this new platform.

More... »

Caliper, Pfizer launch platform for drug safety

Thursday, November 3, 2011 09:02 AM

Caliper Life Sciences, a provider of tools and services for drug
discovery and life sciences research, has launched a new services
offering based on a panel of cellular assays that measure the effects of
drug candidates on functional activity of proteins called kinases involved
in critical cell-signaling pathways. The technology platform and initial
panel of nine assays were developed in collaboration with Pfizer. The new offering, called In-Cell KinaseScreen, is immediately available for compound screening, profiling, and custom assay development services for CDAS' clients, ranging from academia to pharmaceutical companies.

More... »

CoreRx selects Xcelodose to enhance product development

Wednesday, November 2, 2011 12:34 PM

More... »